This is the authors' abstract. We don't add key points for this paper.
Abstract 2-arachnadoyl glycerol (2-AG) is one of the most common endocannabinoid molecules with antiproliferative, cytotoxic and pro-proliferative effects on different types of tumors. Typically, it induces cell death via CB1/CB2-linked ceramide production. In breast cancer, ceramide is counterbalanced by the sphingosine-1-phosphate, and thus the mechanisms of 2-AG influence on proliferation are poorly understood. In this paper, we evaluated the mechanism of the cell death induction by 2-AG and the influence of LPI on it in 6 human breast cancer cell lines of different tumor degree using a novel analog, 2-arachidonoyl-difluoropropanol (2-ADFP). 2-ADFP induced cell death via the CB2 and TRPV1-dependent COX-2 induction and oxidized metabolites production. The activity was enhanced by LPI.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Akimov et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: